Efficacy and Safety of Inetetamab Plus Pyrotiniband and Capecitabine in HER2-positive Metastatic Breast Cancer Patients With or Without Brain Metastasis
Condition: Breast Cancer Intervention: Drug: Inetetamab plus pyrotiniband and capecitabine Sponsor: Yan Xue Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Brain | Brain Cancers | Breast Cancer | Cancer | Cancer & Oncology | HER2 | Neurology | Research | Xeloda